nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C19—epilepsy syndrome	0.165	0.574	CbGaD
Moclobemide—CYP2D6—epilepsy syndrome	0.122	0.426	CbGaD
Moclobemide—MAOB—Zonisamide—epilepsy syndrome	0.0643	0.137	CbGbCtD
Moclobemide—MAOA—Zonisamide—epilepsy syndrome	0.0506	0.107	CbGbCtD
Moclobemide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0213	0.0452	CbGbCtD
Moclobemide—CYP2C19—Felbamate—epilepsy syndrome	0.0198	0.042	CbGbCtD
Moclobemide—CYP2C19—Trimethadione—epilepsy syndrome	0.0198	0.042	CbGbCtD
Moclobemide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0186	0.0395	CbGbCtD
Moclobemide—CYP2C9—Trimethadione—epilepsy syndrome	0.0164	0.0349	CbGbCtD
Moclobemide—CYP2C19—Clobazam—epilepsy syndrome	0.0161	0.0342	CbGbCtD
Moclobemide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0154	0.0328	CbGbCtD
Moclobemide—CYP2C19—Carbamazepine—epilepsy syndrome	0.0134	0.0284	CbGbCtD
Moclobemide—CYP2C19—Primidone—epilepsy syndrome	0.0125	0.0265	CbGbCtD
Moclobemide—CYP1A2—Carbamazepine—epilepsy syndrome	0.0123	0.0262	CbGbCtD
Moclobemide—CYP2C19—Phenytoin—epilepsy syndrome	0.012	0.0254	CbGbCtD
Moclobemide—CYP1A2—Primidone—epilepsy syndrome	0.0115	0.0244	CbGbCtD
Moclobemide—CYP2C19—Propofol—epilepsy syndrome	0.0112	0.0237	CbGbCtD
Moclobemide—CYP2C9—Carbamazepine—epilepsy syndrome	0.0111	0.0236	CbGbCtD
Moclobemide—CYP2C19—Phenobarbital—epilepsy syndrome	0.0107	0.0227	CbGbCtD
Moclobemide—CYP2C9—Primidone—epilepsy syndrome	0.0104	0.022	CbGbCtD
Moclobemide—CYP1A2—Propofol—epilepsy syndrome	0.0103	0.0219	CbGbCtD
Moclobemide—CYP2C19—Diazepam—epilepsy syndrome	0.0101	0.0215	CbGbCtD
Moclobemide—CYP2C9—Phenytoin—epilepsy syndrome	0.00996	0.0211	CbGbCtD
Moclobemide—CYP2C19—Zonisamide—epilepsy syndrome	0.00988	0.021	CbGbCtD
Moclobemide—CYP1A2—Phenobarbital—epilepsy syndrome	0.00985	0.0209	CbGbCtD
Moclobemide—CYP1A2—Diazepam—epilepsy syndrome	0.00934	0.0198	CbGbCtD
Moclobemide—CYP2C9—Propofol—epilepsy syndrome	0.00928	0.0197	CbGbCtD
Moclobemide—CYP2C9—Phenobarbital—epilepsy syndrome	0.00887	0.0188	CbGbCtD
Moclobemide—CYP2D6—Propofol—epilepsy syndrome	0.00849	0.018	CbGbCtD
Moclobemide—CYP2C9—Diazepam—epilepsy syndrome	0.00841	0.0179	CbGbCtD
Moclobemide—CYP2C19—Valproic Acid—epilepsy syndrome	0.00798	0.0169	CbGbCtD
Moclobemide—CYP1A2—Valproic Acid—epilepsy syndrome	0.00736	0.0156	CbGbCtD
Moclobemide—CYP2C19—Topiramate—epilepsy syndrome	0.0072	0.0153	CbGbCtD
Moclobemide—CYP2C9—Valproic Acid—epilepsy syndrome	0.00663	0.0141	CbGbCtD
Moclobemide—MAOA—locus ceruleus—epilepsy syndrome	0.00389	0.213	CbGeAlD
Moclobemide—MAOB—ganglion—epilepsy syndrome	0.00135	0.0737	CbGeAlD
Moclobemide—MAOA—ganglion—epilepsy syndrome	0.00115	0.0629	CbGeAlD
Moclobemide—MAOB—hindbrain—epilepsy syndrome	0.00102	0.0559	CbGeAlD
Moclobemide—MAOA—hindbrain—epilepsy syndrome	0.000871	0.0477	CbGeAlD
Moclobemide—MAOB—brainstem—epilepsy syndrome	0.000585	0.032	CbGeAlD
Moclobemide—MAOB—forebrain—epilepsy syndrome	0.000565	0.0309	CbGeAlD
Moclobemide—Procainamide—SCN8A—epilepsy syndrome	0.000555	0.129	CrCbGaD
Moclobemide—MAOB—telencephalon—epilepsy syndrome	0.00052	0.0284	CbGeAlD
Moclobemide—CYP2D6—hindbrain—epilepsy syndrome	0.000518	0.0283	CbGeAlD
Moclobemide—MAOA—brainstem—epilepsy syndrome	0.000499	0.0273	CbGeAlD
Moclobemide—MAOA—forebrain—epilepsy syndrome	0.000482	0.0264	CbGeAlD
Moclobemide—Procainamide—SCN9A—epilepsy syndrome	0.000449	0.104	CrCbGaD
Moclobemide—MAOA—telencephalon—epilepsy syndrome	0.000443	0.0242	CbGeAlD
Moclobemide—Procainamide—SCN3A—epilepsy syndrome	0.000429	0.0998	CrCbGaD
Moclobemide—Procainamide—SCN4A—epilepsy syndrome	0.000412	0.0959	CrCbGaD
Moclobemide—Minaprine—CHRM1—epilepsy syndrome	0.000409	0.0951	CrCbGaD
Moclobemide—MAOB—medulla oblongata—epilepsy syndrome	0.000408	0.0223	CbGeAlD
Moclobemide—MAOB—midbrain—epilepsy syndrome	0.000373	0.0204	CbGeAlD
Moclobemide—MAOB—spinal cord—epilepsy syndrome	0.000364	0.0199	CbGeAlD
Moclobemide—MAOA—medulla oblongata—epilepsy syndrome	0.000348	0.0191	CbGeAlD
Moclobemide—MAOB—head—epilepsy syndrome	0.000324	0.0177	CbGeAlD
Moclobemide—MAOA—midbrain—epilepsy syndrome	0.000318	0.0174	CbGeAlD
Moclobemide—MAOA—spinal cord—epilepsy syndrome	0.000311	0.017	CbGeAlD
Moclobemide—MAOB—nervous system—epilepsy syndrome	0.000307	0.0168	CbGeAlD
Moclobemide—Procainamide—SCN1A—epilepsy syndrome	0.000301	0.0701	CrCbGaD
Moclobemide—CYP2D6—brainstem—epilepsy syndrome	0.000297	0.0162	CbGeAlD
Moclobemide—MAOB—central nervous system—epilepsy syndrome	0.000295	0.0162	CbGeAlD
Moclobemide—Haloperidol—GRIN2B—epilepsy syndrome	0.000291	0.0677	CrCbGaD
Moclobemide—MAOB—cerebellum—epilepsy syndrome	0.000289	0.0158	CbGeAlD
Moclobemide—CYP2D6—forebrain—epilepsy syndrome	0.000286	0.0157	CbGeAlD
Moclobemide—MAOA—head—epilepsy syndrome	0.000276	0.0151	CbGeAlD
Moclobemide—Procainamide—SCN2A—epilepsy syndrome	0.000266	0.0618	CrCbGaD
Moclobemide—CYP2D6—telencephalon—epilepsy syndrome	0.000263	0.0144	CbGeAlD
Moclobemide—MAOA—nervous system—epilepsy syndrome	0.000262	0.0143	CbGeAlD
Moclobemide—MAOA—central nervous system—epilepsy syndrome	0.000252	0.0138	CbGeAlD
Moclobemide—MAOA—cerebellum—epilepsy syndrome	0.000246	0.0135	CbGeAlD
Moclobemide—MAOB—brain—epilepsy syndrome	0.000234	0.0128	CbGeAlD
Moclobemide—Minaprine—SLC6A4—epilepsy syndrome	0.000218	0.0506	CrCbGaD
Moclobemide—MAOA—brain—epilepsy syndrome	0.0002	0.0109	CbGeAlD
Moclobemide—Minaprine—HTR2A—epilepsy syndrome	0.000167	0.0389	CrCbGaD
Moclobemide—CYP2D6—head—epilepsy syndrome	0.000164	0.00897	CbGeAlD
Moclobemide—CYP2D6—nervous system—epilepsy syndrome	0.000156	0.00851	CbGeAlD
Moclobemide—Procainamide—CHRM2—epilepsy syndrome	0.000153	0.0357	CrCbGaD
Moclobemide—Minaprine—CYP2D6—epilepsy syndrome	0.000153	0.0355	CrCbGaD
Moclobemide—CYP2D6—central nervous system—epilepsy syndrome	0.00015	0.00819	CbGeAlD
Moclobemide—CYP2D6—cerebellum—epilepsy syndrome	0.000146	0.00801	CbGeAlD
Moclobemide—Procainamide—BCHE—epilepsy syndrome	0.000128	0.0297	CrCbGaD
Moclobemide—CYP2D6—brain—epilepsy syndrome	0.000119	0.0065	CbGeAlD
Moclobemide—Haloperidol—CYP2C19—epilepsy syndrome	9.75e-05	0.0227	CrCbGaD
Moclobemide—Haloperidol—HTR2A—epilepsy syndrome	7.91e-05	0.0184	CrCbGaD
Moclobemide—Pruritus—Felbamate—epilepsy syndrome	7.3e-05	0.000426	CcSEcCtD
Moclobemide—Abdominal pain—Carbamazepine—epilepsy syndrome	7.3e-05	0.000426	CcSEcCtD
Moclobemide—Diarrhoea—Diazepam—epilepsy syndrome	7.3e-05	0.000426	CcSEcCtD
Moclobemide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	7.29e-05	0.000426	CcSEcCtD
Moclobemide—Ill-defined disorder—Pregabalin—epilepsy syndrome	7.29e-05	0.000425	CcSEcCtD
Moclobemide—Rash—Levetiracetam—epilepsy syndrome	7.26e-05	0.000424	CcSEcCtD
Moclobemide—Dermatitis—Levetiracetam—epilepsy syndrome	7.25e-05	0.000423	CcSEcCtD
Moclobemide—Asthenia—Zonisamide—epilepsy syndrome	7.25e-05	0.000423	CcSEcCtD
Moclobemide—Dry mouth—Valproic Acid—epilepsy syndrome	7.23e-05	0.000422	CcSEcCtD
Moclobemide—Haloperidol—CYP2D6—epilepsy syndrome	7.23e-05	0.0168	CrCbGaD
Moclobemide—Agitation—Pregabalin—epilepsy syndrome	7.22e-05	0.000421	CcSEcCtD
Moclobemide—Headache—Levetiracetam—epilepsy syndrome	7.21e-05	0.000421	CcSEcCtD
Moclobemide—Dizziness—Vigabatrin—epilepsy syndrome	7.16e-05	0.000418	CcSEcCtD
Moclobemide—Confusional state—Valproic Acid—epilepsy syndrome	7.15e-05	0.000417	CcSEcCtD
Moclobemide—Pruritus—Zonisamide—epilepsy syndrome	7.15e-05	0.000417	CcSEcCtD
Moclobemide—Flatulence—Gabapentin—epilepsy syndrome	7.1e-05	0.000414	CcSEcCtD
Moclobemide—Urticaria—Lamotrigine—epilepsy syndrome	7.09e-05	0.000414	CcSEcCtD
Moclobemide—Bradycardia—Topiramate—epilepsy syndrome	7.08e-05	0.000414	CcSEcCtD
Moclobemide—Malaise—Pregabalin—epilepsy syndrome	7.08e-05	0.000414	CcSEcCtD
Moclobemide—Nausea—Propofol—epilepsy syndrome	7.08e-05	0.000413	CcSEcCtD
Moclobemide—Tension—Gabapentin—epilepsy syndrome	7.07e-05	0.000413	CcSEcCtD
Moclobemide—Vomiting—Fosphenytoin—epilepsy syndrome	7.06e-05	0.000413	CcSEcCtD
Moclobemide—Diarrhoea—Felbamate—epilepsy syndrome	7.06e-05	0.000412	CcSEcCtD
Moclobemide—Abdominal pain—Lamotrigine—epilepsy syndrome	7.05e-05	0.000412	CcSEcCtD
Moclobemide—Dysgeusia—Gabapentin—epilepsy syndrome	7.05e-05	0.000412	CcSEcCtD
Moclobemide—Dizziness—Diazepam—epilepsy syndrome	7.05e-05	0.000412	CcSEcCtD
Moclobemide—Syncope—Pregabalin—epilepsy syndrome	7.04e-05	0.000411	CcSEcCtD
Moclobemide—Procainamide—CYP2D6—epilepsy syndrome	7.02e-05	0.0163	CrCbGaD
Moclobemide—Rash—Fosphenytoin—epilepsy syndrome	7.01e-05	0.000409	CcSEcCtD
Moclobemide—Dermatitis—Fosphenytoin—epilepsy syndrome	7e-05	0.000409	CcSEcCtD
Moclobemide—Nervousness—Gabapentin—epilepsy syndrome	6.99e-05	0.000408	CcSEcCtD
Moclobemide—Asthenia—Clonazepam—epilepsy syndrome	6.98e-05	0.000408	CcSEcCtD
Moclobemide—Headache—Fosphenytoin—epilepsy syndrome	6.96e-05	0.000406	CcSEcCtD
Moclobemide—Palpitations—Pregabalin—epilepsy syndrome	6.94e-05	0.000405	CcSEcCtD
Moclobemide—Asthenia—Phenytoin—epilepsy syndrome	6.94e-05	0.000405	CcSEcCtD
Moclobemide—Nausea—Midazolam—epilepsy syndrome	6.92e-05	0.000404	CcSEcCtD
Moclobemide—Hallucination—Topiramate—epilepsy syndrome	6.92e-05	0.000404	CcSEcCtD
Moclobemide—Tachycardia—Valproic Acid—epilepsy syndrome	6.92e-05	0.000404	CcSEcCtD
Moclobemide—Diarrhoea—Zonisamide—epilepsy syndrome	6.91e-05	0.000404	CcSEcCtD
Moclobemide—Loss of consciousness—Pregabalin—epilepsy syndrome	6.9e-05	0.000403	CcSEcCtD
Moclobemide—Asthenia—Oxcarbazepine—epilepsy syndrome	6.9e-05	0.000403	CcSEcCtD
Moclobemide—Pruritus—Clonazepam—epilepsy syndrome	6.89e-05	0.000402	CcSEcCtD
Moclobemide—Vomiting—Vigabatrin—epilepsy syndrome	6.89e-05	0.000402	CcSEcCtD
Moclobemide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.85e-05	0.0004	CcSEcCtD
Moclobemide—Pruritus—Phenytoin—epilepsy syndrome	6.84e-05	0.0004	CcSEcCtD
Moclobemide—Nausea—Levetiracetam—epilepsy syndrome	6.84e-05	0.000399	CcSEcCtD
Moclobemide—Rash—Vigabatrin—epilepsy syndrome	6.83e-05	0.000399	CcSEcCtD
Moclobemide—Dizziness—Felbamate—epilepsy syndrome	6.82e-05	0.000399	CcSEcCtD
Moclobemide—Dermatitis—Vigabatrin—epilepsy syndrome	6.82e-05	0.000398	CcSEcCtD
Moclobemide—Pruritus—Oxcarbazepine—epilepsy syndrome	6.81e-05	0.000397	CcSEcCtD
Moclobemide—Vision blurred—Gabapentin—epilepsy syndrome	6.79e-05	0.000396	CcSEcCtD
Moclobemide—Headache—Vigabatrin—epilepsy syndrome	6.78e-05	0.000396	CcSEcCtD
Moclobemide—Hypertension—Pregabalin—epilepsy syndrome	6.78e-05	0.000396	CcSEcCtD
Moclobemide—Vomiting—Diazepam—epilepsy syndrome	6.78e-05	0.000396	CcSEcCtD
Moclobemide—Tremor—Gabapentin—epilepsy syndrome	6.75e-05	0.000394	CcSEcCtD
Moclobemide—Rash—Diazepam—epilepsy syndrome	6.72e-05	0.000393	CcSEcCtD
Moclobemide—Dermatitis—Diazepam—epilepsy syndrome	6.72e-05	0.000392	CcSEcCtD
Moclobemide—Visual impairment—Topiramate—epilepsy syndrome	6.71e-05	0.000392	CcSEcCtD
Moclobemide—Chest pain—Pregabalin—epilepsy syndrome	6.69e-05	0.00039	CcSEcCtD
Moclobemide—Myalgia—Pregabalin—epilepsy syndrome	6.69e-05	0.00039	CcSEcCtD
Moclobemide—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.68e-05	0.00039	CcSEcCtD
Moclobemide—Dizziness—Zonisamide—epilepsy syndrome	6.68e-05	0.00039	CcSEcCtD
Moclobemide—Headache—Diazepam—epilepsy syndrome	6.68e-05	0.00039	CcSEcCtD
Moclobemide—Anxiety—Pregabalin—epilepsy syndrome	6.66e-05	0.000389	CcSEcCtD
Moclobemide—Diarrhoea—Clonazepam—epilepsy syndrome	6.66e-05	0.000389	CcSEcCtD
Moclobemide—Hypotension—Valproic Acid—epilepsy syndrome	6.62e-05	0.000387	CcSEcCtD
Moclobemide—Asthenia—Carbamazepine—epilepsy syndrome	6.62e-05	0.000387	CcSEcCtD
Moclobemide—Agitation—Gabapentin—epilepsy syndrome	6.62e-05	0.000386	CcSEcCtD
Moclobemide—Diarrhoea—Phenytoin—epilepsy syndrome	6.62e-05	0.000386	CcSEcCtD
Moclobemide—Discomfort—Pregabalin—epilepsy syndrome	6.61e-05	0.000386	CcSEcCtD
Moclobemide—Nausea—Fosphenytoin—epilepsy syndrome	6.6e-05	0.000385	CcSEcCtD
Moclobemide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.58e-05	0.000384	CcSEcCtD
Moclobemide—Vomiting—Felbamate—epilepsy syndrome	6.56e-05	0.000383	CcSEcCtD
Moclobemide—Dry mouth—Pregabalin—epilepsy syndrome	6.54e-05	0.000382	CcSEcCtD
Moclobemide—Pruritus—Carbamazepine—epilepsy syndrome	6.53e-05	0.000381	CcSEcCtD
Moclobemide—Rash—Felbamate—epilepsy syndrome	6.51e-05	0.00038	CcSEcCtD
Moclobemide—Dermatitis—Felbamate—epilepsy syndrome	6.5e-05	0.00038	CcSEcCtD
Moclobemide—Malaise—Gabapentin—epilepsy syndrome	6.49e-05	0.000379	CcSEcCtD
Moclobemide—Tinnitus—Topiramate—epilepsy syndrome	6.49e-05	0.000379	CcSEcCtD
Moclobemide—Headache—Felbamate—epilepsy syndrome	6.46e-05	0.000378	CcSEcCtD
Moclobemide—Confusional state—Pregabalin—epilepsy syndrome	6.46e-05	0.000377	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.46e-05	0.000377	CcSEcCtD
Moclobemide—Flushing—Topiramate—epilepsy syndrome	6.46e-05	0.000377	CcSEcCtD
Moclobemide—Syncope—Gabapentin—epilepsy syndrome	6.46e-05	0.000377	CcSEcCtD
Moclobemide—Dizziness—Clonazepam—epilepsy syndrome	6.44e-05	0.000376	CcSEcCtD
Moclobemide—Nausea—Vigabatrin—epilepsy syndrome	6.43e-05	0.000376	CcSEcCtD
Moclobemide—Vomiting—Zonisamide—epilepsy syndrome	6.42e-05	0.000375	CcSEcCtD
Moclobemide—Insomnia—Valproic Acid—epilepsy syndrome	6.41e-05	0.000374	CcSEcCtD
Moclobemide—Asthenia—Lamotrigine—epilepsy syndrome	6.4e-05	0.000374	CcSEcCtD
Moclobemide—Dizziness—Phenytoin—epilepsy syndrome	6.39e-05	0.000373	CcSEcCtD
Moclobemide—Rash—Zonisamide—epilepsy syndrome	6.37e-05	0.000372	CcSEcCtD
Moclobemide—Paraesthesia—Valproic Acid—epilepsy syndrome	6.37e-05	0.000372	CcSEcCtD
Moclobemide—Palpitations—Gabapentin—epilepsy syndrome	6.36e-05	0.000372	CcSEcCtD
Moclobemide—Dermatitis—Zonisamide—epilepsy syndrome	6.36e-05	0.000372	CcSEcCtD
Moclobemide—Dizziness—Oxcarbazepine—epilepsy syndrome	6.36e-05	0.000371	CcSEcCtD
Moclobemide—Nausea—Diazepam—epilepsy syndrome	6.33e-05	0.00037	CcSEcCtD
Moclobemide—Loss of consciousness—Gabapentin—epilepsy syndrome	6.33e-05	0.00037	CcSEcCtD
Moclobemide—Headache—Zonisamide—epilepsy syndrome	6.33e-05	0.00037	CcSEcCtD
Moclobemide—Dyspnoea—Valproic Acid—epilepsy syndrome	6.32e-05	0.000369	CcSEcCtD
Moclobemide—Diarrhoea—Carbamazepine—epilepsy syndrome	6.32e-05	0.000369	CcSEcCtD
Moclobemide—Pruritus—Lamotrigine—epilepsy syndrome	6.31e-05	0.000369	CcSEcCtD
Moclobemide—Shock—Pregabalin—epilepsy syndrome	6.31e-05	0.000368	CcSEcCtD
Moclobemide—Somnolence—Valproic Acid—epilepsy syndrome	6.3e-05	0.000368	CcSEcCtD
Moclobemide—Tachycardia—Pregabalin—epilepsy syndrome	6.25e-05	0.000365	CcSEcCtD
Moclobemide—Dyspepsia—Valproic Acid—epilepsy syndrome	6.24e-05	0.000364	CcSEcCtD
Moclobemide—Hypertension—Gabapentin—epilepsy syndrome	6.22e-05	0.000363	CcSEcCtD
Moclobemide—Hyperhidrosis—Pregabalin—epilepsy syndrome	6.2e-05	0.000362	CcSEcCtD
Moclobemide—Vomiting—Clonazepam—epilepsy syndrome	6.19e-05	0.000361	CcSEcCtD
Moclobemide—Decreased appetite—Valproic Acid—epilepsy syndrome	6.16e-05	0.00036	CcSEcCtD
Moclobemide—Vomiting—Phenytoin—epilepsy syndrome	6.15e-05	0.000359	CcSEcCtD
Moclobemide—Rash—Clonazepam—epilepsy syndrome	6.14e-05	0.000358	CcSEcCtD
Moclobemide—Dermatitis—Clonazepam—epilepsy syndrome	6.13e-05	0.000358	CcSEcCtD
Moclobemide—Chest pain—Gabapentin—epilepsy syndrome	6.13e-05	0.000358	CcSEcCtD
Moclobemide—Myalgia—Gabapentin—epilepsy syndrome	6.13e-05	0.000358	CcSEcCtD
Moclobemide—Nausea—Felbamate—epilepsy syndrome	6.13e-05	0.000358	CcSEcCtD
Moclobemide—Vomiting—Oxcarbazepine—epilepsy syndrome	6.12e-05	0.000357	CcSEcCtD
Moclobemide—Fatigue—Valproic Acid—epilepsy syndrome	6.11e-05	0.000357	CcSEcCtD
Moclobemide—Anxiety—Gabapentin—epilepsy syndrome	6.11e-05	0.000357	CcSEcCtD
Moclobemide—Dizziness—Carbamazepine—epilepsy syndrome	6.1e-05	0.000356	CcSEcCtD
Moclobemide—Diarrhoea—Lamotrigine—epilepsy syndrome	6.1e-05	0.000356	CcSEcCtD
Moclobemide—Headache—Clonazepam—epilepsy syndrome	6.1e-05	0.000356	CcSEcCtD
Moclobemide—Rash—Phenytoin—epilepsy syndrome	6.1e-05	0.000356	CcSEcCtD
Moclobemide—Dermatitis—Phenytoin—epilepsy syndrome	6.09e-05	0.000356	CcSEcCtD
Moclobemide—Rash—Oxcarbazepine—epilepsy syndrome	6.06e-05	0.000354	CcSEcCtD
Moclobemide—Constipation—Valproic Acid—epilepsy syndrome	6.06e-05	0.000354	CcSEcCtD
Moclobemide—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.06e-05	0.000354	CcSEcCtD
Moclobemide—Headache—Phenytoin—epilepsy syndrome	6.06e-05	0.000354	CcSEcCtD
Moclobemide—Discomfort—Gabapentin—epilepsy syndrome	6.06e-05	0.000354	CcSEcCtD
Moclobemide—Headache—Oxcarbazepine—epilepsy syndrome	6.03e-05	0.000352	CcSEcCtD
Moclobemide—Nausea—Zonisamide—epilepsy syndrome	6e-05	0.00035	CcSEcCtD
Moclobemide—Dry mouth—Gabapentin—epilepsy syndrome	6e-05	0.00035	CcSEcCtD
Moclobemide—Hypotension—Pregabalin—epilepsy syndrome	5.99e-05	0.00035	CcSEcCtD
Moclobemide—Flatulence—Topiramate—epilepsy syndrome	5.97e-05	0.000349	CcSEcCtD
Moclobemide—Tension—Topiramate—epilepsy syndrome	5.94e-05	0.000347	CcSEcCtD
Moclobemide—Dysgeusia—Topiramate—epilepsy syndrome	5.93e-05	0.000346	CcSEcCtD
Moclobemide—Confusional state—Gabapentin—epilepsy syndrome	5.93e-05	0.000346	CcSEcCtD
Moclobemide—Dizziness—Lamotrigine—epilepsy syndrome	5.9e-05	0.000344	CcSEcCtD
Moclobemide—Nervousness—Topiramate—epilepsy syndrome	5.88e-05	0.000344	CcSEcCtD
Moclobemide—Vomiting—Carbamazepine—epilepsy syndrome	5.87e-05	0.000343	CcSEcCtD
Moclobemide—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.84e-05	0.000341	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.84e-05	0.000341	CcSEcCtD
Moclobemide—Rash—Carbamazepine—epilepsy syndrome	5.82e-05	0.00034	CcSEcCtD
Moclobemide—Dermatitis—Carbamazepine—epilepsy syndrome	5.81e-05	0.00034	CcSEcCtD
Moclobemide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.8e-05	0.000339	CcSEcCtD
Moclobemide—Insomnia—Pregabalin—epilepsy syndrome	5.8e-05	0.000338	CcSEcCtD
Moclobemide—Nausea—Clonazepam—epilepsy syndrome	5.78e-05	0.000338	CcSEcCtD
Moclobemide—Headache—Carbamazepine—epilepsy syndrome	5.78e-05	0.000338	CcSEcCtD
Moclobemide—Shock—Gabapentin—epilepsy syndrome	5.78e-05	0.000338	CcSEcCtD
Moclobemide—Paraesthesia—Pregabalin—epilepsy syndrome	5.75e-05	0.000336	CcSEcCtD
Moclobemide—Nausea—Phenytoin—epilepsy syndrome	5.74e-05	0.000335	CcSEcCtD
Moclobemide—Tachycardia—Gabapentin—epilepsy syndrome	5.74e-05	0.000335	CcSEcCtD
Moclobemide—Dyspnoea—Pregabalin—epilepsy syndrome	5.71e-05	0.000334	CcSEcCtD
Moclobemide—Nausea—Oxcarbazepine—epilepsy syndrome	5.71e-05	0.000334	CcSEcCtD
Moclobemide—Vision blurred—Topiramate—epilepsy syndrome	5.71e-05	0.000333	CcSEcCtD
Moclobemide—Somnolence—Pregabalin—epilepsy syndrome	5.7e-05	0.000333	CcSEcCtD
Moclobemide—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.68e-05	0.000332	CcSEcCtD
Moclobemide—Tremor—Topiramate—epilepsy syndrome	5.68e-05	0.000331	CcSEcCtD
Moclobemide—Vomiting—Lamotrigine—epilepsy syndrome	5.67e-05	0.000331	CcSEcCtD
Moclobemide—Urticaria—Valproic Acid—epilepsy syndrome	5.63e-05	0.000329	CcSEcCtD
Moclobemide—Rash—Lamotrigine—epilepsy syndrome	5.62e-05	0.000328	CcSEcCtD
Moclobemide—Ill-defined disorder—Topiramate—epilepsy syndrome	5.62e-05	0.000328	CcSEcCtD
Moclobemide—Dermatitis—Lamotrigine—epilepsy syndrome	5.62e-05	0.000328	CcSEcCtD
Moclobemide—Abdominal pain—Valproic Acid—epilepsy syndrome	5.6e-05	0.000327	CcSEcCtD
Moclobemide—Headache—Lamotrigine—epilepsy syndrome	5.59e-05	0.000326	CcSEcCtD
Moclobemide—Decreased appetite—Pregabalin—epilepsy syndrome	5.57e-05	0.000325	CcSEcCtD
Moclobemide—Agitation—Topiramate—epilepsy syndrome	5.57e-05	0.000325	CcSEcCtD
Moclobemide—Fatigue—Pregabalin—epilepsy syndrome	5.53e-05	0.000323	CcSEcCtD
Moclobemide—Hypotension—Gabapentin—epilepsy syndrome	5.49e-05	0.000321	CcSEcCtD
Moclobemide—Nausea—Carbamazepine—epilepsy syndrome	5.48e-05	0.00032	CcSEcCtD
Moclobemide—Constipation—Pregabalin—epilepsy syndrome	5.48e-05	0.00032	CcSEcCtD
Moclobemide—Malaise—Topiramate—epilepsy syndrome	5.46e-05	0.000319	CcSEcCtD
Moclobemide—Syncope—Topiramate—epilepsy syndrome	5.43e-05	0.000317	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.35e-05	0.000313	CcSEcCtD
Moclobemide—Palpitations—Topiramate—epilepsy syndrome	5.35e-05	0.000313	CcSEcCtD
Moclobemide—Loss of consciousness—Topiramate—epilepsy syndrome	5.32e-05	0.000311	CcSEcCtD
Moclobemide—Insomnia—Gabapentin—epilepsy syndrome	5.32e-05	0.00031	CcSEcCtD
Moclobemide—Nausea—Lamotrigine—epilepsy syndrome	5.3e-05	0.000309	CcSEcCtD
Moclobemide—Feeling abnormal—Pregabalin—epilepsy syndrome	5.28e-05	0.000308	CcSEcCtD
Moclobemide—Paraesthesia—Gabapentin—epilepsy syndrome	5.28e-05	0.000308	CcSEcCtD
Moclobemide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.24e-05	0.000306	CcSEcCtD
Moclobemide—Dyspnoea—Gabapentin—epilepsy syndrome	5.24e-05	0.000306	CcSEcCtD
Moclobemide—Hypertension—Topiramate—epilepsy syndrome	5.23e-05	0.000305	CcSEcCtD
Moclobemide—Somnolence—Gabapentin—epilepsy syndrome	5.22e-05	0.000305	CcSEcCtD
Moclobemide—Dyspepsia—Gabapentin—epilepsy syndrome	5.17e-05	0.000302	CcSEcCtD
Moclobemide—Haloperidol—ABCB1—epilepsy syndrome	5.16e-05	0.012	CrCbGaD
Moclobemide—Chest pain—Topiramate—epilepsy syndrome	5.16e-05	0.000301	CcSEcCtD
Moclobemide—Myalgia—Topiramate—epilepsy syndrome	5.16e-05	0.000301	CcSEcCtD
Moclobemide—Anxiety—Topiramate—epilepsy syndrome	5.14e-05	0.0003	CcSEcCtD
Moclobemide—Decreased appetite—Gabapentin—epilepsy syndrome	5.11e-05	0.000298	CcSEcCtD
Moclobemide—Discomfort—Topiramate—epilepsy syndrome	5.1e-05	0.000298	CcSEcCtD
Moclobemide—Urticaria—Pregabalin—epilepsy syndrome	5.09e-05	0.000297	CcSEcCtD
Moclobemide—Asthenia—Valproic Acid—epilepsy syndrome	5.09e-05	0.000297	CcSEcCtD
Moclobemide—Fatigue—Gabapentin—epilepsy syndrome	5.07e-05	0.000296	CcSEcCtD
Moclobemide—Abdominal pain—Pregabalin—epilepsy syndrome	5.07e-05	0.000296	CcSEcCtD
Moclobemide—Dry mouth—Topiramate—epilepsy syndrome	5.04e-05	0.000295	CcSEcCtD
Moclobemide—Constipation—Gabapentin—epilepsy syndrome	5.03e-05	0.000293	CcSEcCtD
Moclobemide—Pruritus—Valproic Acid—epilepsy syndrome	5.02e-05	0.000293	CcSEcCtD
Moclobemide—Confusional state—Topiramate—epilepsy syndrome	4.99e-05	0.000291	CcSEcCtD
Moclobemide—Shock—Topiramate—epilepsy syndrome	4.86e-05	0.000284	CcSEcCtD
Moclobemide—Diarrhoea—Valproic Acid—epilepsy syndrome	4.85e-05	0.000283	CcSEcCtD
Moclobemide—Feeling abnormal—Gabapentin—epilepsy syndrome	4.84e-05	0.000283	CcSEcCtD
Moclobemide—Tachycardia—Topiramate—epilepsy syndrome	4.83e-05	0.000282	CcSEcCtD
Moclobemide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.81e-05	0.000281	CcSEcCtD
Moclobemide—Hyperhidrosis—Topiramate—epilepsy syndrome	4.78e-05	0.000279	CcSEcCtD
Moclobemide—Dizziness—Valproic Acid—epilepsy syndrome	4.69e-05	0.000274	CcSEcCtD
Moclobemide—Urticaria—Gabapentin—epilepsy syndrome	4.67e-05	0.000273	CcSEcCtD
Moclobemide—Abdominal pain—Gabapentin—epilepsy syndrome	4.65e-05	0.000271	CcSEcCtD
Moclobemide—Hypotension—Topiramate—epilepsy syndrome	4.62e-05	0.00027	CcSEcCtD
Moclobemide—Asthenia—Pregabalin—epilepsy syndrome	4.6e-05	0.000269	CcSEcCtD
Moclobemide—Pruritus—Pregabalin—epilepsy syndrome	4.53e-05	0.000265	CcSEcCtD
Moclobemide—Vomiting—Valproic Acid—epilepsy syndrome	4.51e-05	0.000263	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.5e-05	0.000263	CcSEcCtD
Moclobemide—Insomnia—Topiramate—epilepsy syndrome	4.47e-05	0.000261	CcSEcCtD
Moclobemide—Rash—Valproic Acid—epilepsy syndrome	4.47e-05	0.000261	CcSEcCtD
Moclobemide—Dermatitis—Valproic Acid—epilepsy syndrome	4.47e-05	0.000261	CcSEcCtD
Moclobemide—Headache—Valproic Acid—epilepsy syndrome	4.44e-05	0.000259	CcSEcCtD
Moclobemide—Paraesthesia—Topiramate—epilepsy syndrome	4.44e-05	0.000259	CcSEcCtD
Moclobemide—Dyspnoea—Topiramate—epilepsy syndrome	4.41e-05	0.000257	CcSEcCtD
Moclobemide—Somnolence—Topiramate—epilepsy syndrome	4.4e-05	0.000257	CcSEcCtD
Moclobemide—Diarrhoea—Pregabalin—epilepsy syndrome	4.38e-05	0.000256	CcSEcCtD
Moclobemide—Dyspepsia—Topiramate—epilepsy syndrome	4.35e-05	0.000254	CcSEcCtD
Moclobemide—Decreased appetite—Topiramate—epilepsy syndrome	4.3e-05	0.000251	CcSEcCtD
Moclobemide—Fatigue—Topiramate—epilepsy syndrome	4.26e-05	0.000249	CcSEcCtD
Moclobemide—Dizziness—Pregabalin—epilepsy syndrome	4.24e-05	0.000247	CcSEcCtD
Moclobemide—Constipation—Topiramate—epilepsy syndrome	4.23e-05	0.000247	CcSEcCtD
Moclobemide—Asthenia—Gabapentin—epilepsy syndrome	4.22e-05	0.000246	CcSEcCtD
Moclobemide—Nausea—Valproic Acid—epilepsy syndrome	4.21e-05	0.000246	CcSEcCtD
Moclobemide—Pruritus—Gabapentin—epilepsy syndrome	4.16e-05	0.000243	CcSEcCtD
Moclobemide—Vomiting—Pregabalin—epilepsy syndrome	4.07e-05	0.000238	CcSEcCtD
Moclobemide—Feeling abnormal—Topiramate—epilepsy syndrome	4.07e-05	0.000238	CcSEcCtD
Moclobemide—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.04e-05	0.000236	CcSEcCtD
Moclobemide—Rash—Pregabalin—epilepsy syndrome	4.04e-05	0.000236	CcSEcCtD
Moclobemide—Dermatitis—Pregabalin—epilepsy syndrome	4.04e-05	0.000236	CcSEcCtD
Moclobemide—Diarrhoea—Gabapentin—epilepsy syndrome	4.02e-05	0.000235	CcSEcCtD
Moclobemide—Headache—Pregabalin—epilepsy syndrome	4.01e-05	0.000234	CcSEcCtD
Moclobemide—Urticaria—Topiramate—epilepsy syndrome	3.93e-05	0.000229	CcSEcCtD
Moclobemide—Abdominal pain—Topiramate—epilepsy syndrome	3.91e-05	0.000228	CcSEcCtD
Moclobemide—Dizziness—Gabapentin—epilepsy syndrome	3.89e-05	0.000227	CcSEcCtD
Moclobemide—Nausea—Pregabalin—epilepsy syndrome	3.81e-05	0.000222	CcSEcCtD
Moclobemide—Vomiting—Gabapentin—epilepsy syndrome	3.74e-05	0.000218	CcSEcCtD
Moclobemide—Rash—Gabapentin—epilepsy syndrome	3.71e-05	0.000216	CcSEcCtD
Moclobemide—Dermatitis—Gabapentin—epilepsy syndrome	3.7e-05	0.000216	CcSEcCtD
Moclobemide—Headache—Gabapentin—epilepsy syndrome	3.68e-05	0.000215	CcSEcCtD
Moclobemide—Asthenia—Topiramate—epilepsy syndrome	3.55e-05	0.000207	CcSEcCtD
Moclobemide—Pruritus—Topiramate—epilepsy syndrome	3.5e-05	0.000204	CcSEcCtD
Moclobemide—Nausea—Gabapentin—epilepsy syndrome	3.49e-05	0.000204	CcSEcCtD
Moclobemide—Diarrhoea—Topiramate—epilepsy syndrome	3.38e-05	0.000198	CcSEcCtD
Moclobemide—Dizziness—Topiramate—epilepsy syndrome	3.27e-05	0.000191	CcSEcCtD
Moclobemide—Vomiting—Topiramate—epilepsy syndrome	3.14e-05	0.000184	CcSEcCtD
Moclobemide—Rash—Topiramate—epilepsy syndrome	3.12e-05	0.000182	CcSEcCtD
Moclobemide—Dermatitis—Topiramate—epilepsy syndrome	3.11e-05	0.000182	CcSEcCtD
Moclobemide—Headache—Topiramate—epilepsy syndrome	3.1e-05	0.000181	CcSEcCtD
Moclobemide—Nausea—Topiramate—epilepsy syndrome	2.94e-05	0.000171	CcSEcCtD
Moclobemide—CYP2D6—Metabolism—QDPR—epilepsy syndrome	1.42e-05	0.000298	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	1.42e-05	0.000297	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—L2HGDH—epilepsy syndrome	1.42e-05	0.000297	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ADK—epilepsy syndrome	1.42e-05	0.000297	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GLUD1—epilepsy syndrome	1.42e-05	0.000297	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CERS1—epilepsy syndrome	1.42e-05	0.000297	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PDXK—epilepsy syndrome	1.42e-05	0.000297	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—FAR1—epilepsy syndrome	1.42e-05	0.000297	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.41e-05	0.000296	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.41e-05	0.000296	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.41e-05	0.000295	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	1.38e-05	0.000289	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	1.38e-05	0.000289	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PFKL—epilepsy syndrome	1.38e-05	0.000289	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	1.38e-05	0.000289	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	1.38e-05	0.000289	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—HMOX1—epilepsy syndrome	1.35e-05	0.000283	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.34e-05	0.000281	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—COX3—epilepsy syndrome	1.34e-05	0.00028	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CAT—epilepsy syndrome	1.33e-05	0.000279	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.33e-05	0.000278	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ABCG2—epilepsy syndrome	1.3e-05	0.000273	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PNPO—epilepsy syndrome	1.3e-05	0.000272	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	1.3e-05	0.000272	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	1.3e-05	0.000272	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GAMT—epilepsy syndrome	1.3e-05	0.000272	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ABCB1—epilepsy syndrome	1.29e-05	0.000271	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PFKL—epilepsy syndrome	1.27e-05	0.000266	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	1.27e-05	0.000266	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	1.27e-05	0.000266	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	1.27e-05	0.000266	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	1.27e-05	0.000266	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP2C19—epilepsy syndrome	1.27e-05	0.000266	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ATIC—epilepsy syndrome	1.26e-05	0.000264	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NEU1—epilepsy syndrome	1.26e-05	0.000264	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—UPB1—epilepsy syndrome	1.26e-05	0.000264	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP11A1—epilepsy syndrome	1.26e-05	0.000264	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.26e-05	0.000264	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.26e-05	0.000264	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.26e-05	0.000264	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.26e-05	0.000264	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.26e-05	0.000264	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.23e-05	0.000258	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.22e-05	0.000256	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	1.21e-05	0.000254	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—QDPR—epilepsy syndrome	1.21e-05	0.000253	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CA4—epilepsy syndrome	1.21e-05	0.000253	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GPX1—epilepsy syndrome	1.2e-05	0.000252	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	1.2e-05	0.000252	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GBE1—epilepsy syndrome	1.17e-05	0.000246	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	1.17e-05	0.000246	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NEU1—epilepsy syndrome	1.16e-05	0.000243	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—UPB1—epilepsy syndrome	1.16e-05	0.000243	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ATIC—epilepsy syndrome	1.16e-05	0.000243	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.15e-05	0.000241	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.15e-05	0.000241	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.15e-05	0.000241	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.15e-05	0.00024	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP2D6—epilepsy syndrome	1.14e-05	0.000238	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—COX3—epilepsy syndrome	1.13e-05	0.000238	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	1.12e-05	0.000234	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.11e-05	0.000232	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	1.1e-05	0.000231	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ADRA2A—epilepsy syndrome	1.08e-05	0.000227	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	1.08e-05	0.000226	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GBE1—epilepsy syndrome	1.08e-05	0.000226	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—BCHE—epilepsy syndrome	1.08e-05	0.000226	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	1.07e-05	0.000225	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PFKL—epilepsy syndrome	1.07e-05	0.000225	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	1.07e-05	0.000225	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	1.07e-05	0.000225	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	1.07e-05	0.000225	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	1.07e-05	0.000225	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.07e-05	0.000224	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.07e-05	0.000224	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AGT—epilepsy syndrome	1.06e-05	0.000221	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.05e-05	0.00022	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NT5E—epilepsy syndrome	1.05e-05	0.000219	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALAD—epilepsy syndrome	1.05e-05	0.000219	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.04e-05	0.000219	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.04e-05	0.000219	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—APOE—epilepsy syndrome	1.03e-05	0.000217	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—SLC2A1—epilepsy syndrome	1.03e-05	0.000216	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PLCB1—epilepsy syndrome	1.02e-05	0.000213	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.01e-05	0.000213	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—TH—epilepsy syndrome	1.01e-05	0.000212	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.01e-05	0.000211	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	9.97e-06	0.000209	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	9.97e-06	0.000209	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	9.86e-06	0.000207	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—UPB1—epilepsy syndrome	9.83e-06	0.000206	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ATIC—epilepsy syndrome	9.83e-06	0.000206	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NEU1—epilepsy syndrome	9.83e-06	0.000206	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	9.78e-06	0.000205	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	9.76e-06	0.000205	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NT5E—epilepsy syndrome	9.61e-06	0.000201	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALAD—epilepsy syndrome	9.61e-06	0.000201	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ADSL—epilepsy syndrome	9.56e-06	0.0002	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NT5E—epilepsy syndrome	9.53e-06	0.0002	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALAD—epilepsy syndrome	9.53e-06	0.0002	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	9.46e-06	0.000198	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GLUL—epilepsy syndrome	9.37e-06	0.000196	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	9.2e-06	0.000193	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	9.17e-06	0.000192	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	9.17e-06	0.000192	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GBE1—epilepsy syndrome	9.14e-06	0.000191	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	9.14e-06	0.000191	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	9.09e-06	0.000191	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	9.09e-06	0.000191	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	8.97e-06	0.000188	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.93e-06	0.000187	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	8.9e-06	0.000186	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—POMC—epilepsy syndrome	8.88e-06	0.000186	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ADSL—epilepsy syndrome	8.79e-06	0.000184	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	8.72e-06	0.000183	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GLUL—epilepsy syndrome	8.62e-06	0.000181	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	8.61e-06	0.00018	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	8.59e-06	0.00018	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	8.55e-06	0.000179	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	8.46e-06	0.000177	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—HMOX1—epilepsy syndrome	8.46e-06	0.000177	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	8.39e-06	0.000176	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	8.36e-06	0.000175	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AQP1—epilepsy syndrome	8.35e-06	0.000175	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CAT—epilepsy syndrome	8.35e-06	0.000175	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NT5E—epilepsy syndrome	8.14e-06	0.000171	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALAD—epilepsy syndrome	8.14e-06	0.000171	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ABCB1—epilepsy syndrome	8.12e-06	0.00017	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ALB—epilepsy syndrome	8.1e-06	0.00017	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.02e-06	0.000168	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	7.92e-06	0.000166	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	7.85e-06	0.000164	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	7.77e-06	0.000163	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	7.77e-06	0.000163	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	7.68e-06	0.000161	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	7.62e-06	0.00016	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	7.6e-06	0.000159	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	7.56e-06	0.000158	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	7.56e-06	0.000158	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GPX1—epilepsy syndrome	7.55e-06	0.000158	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ADSL—epilepsy syndrome	7.45e-06	0.000156	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.32e-06	0.000153	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GLUL—epilepsy syndrome	7.3e-06	0.000153	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	7.17e-06	0.00015	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS2—epilepsy syndrome	7.08e-06	0.000148	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.04e-06	0.000147	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	6.95e-06	0.000146	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	6.95e-06	0.000146	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.89e-06	0.000145	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	6.89e-06	0.000144	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	6.89e-06	0.000144	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	6.71e-06	0.000141	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AGT—epilepsy syndrome	6.62e-06	0.000139	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AQP1—epilepsy syndrome	6.51e-06	0.000136	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—APOE—epilepsy syndrome	6.49e-06	0.000136	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.42e-06	0.000134	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.29e-06	0.000132	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.25e-06	0.000131	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	6.16e-06	0.000129	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	5.97e-06	0.000125	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.92e-06	0.000124	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	5.89e-06	0.000123	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	5.89e-06	0.000123	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	5.67e-06	0.000119	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	5.62e-06	0.000118	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—POMC—epilepsy syndrome	5.57e-06	0.000117	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	5.52e-06	0.000116	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	5.49e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.48e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	5.47e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	5.44e-06	0.000114	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.4e-06	0.000113	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.4e-06	0.000113	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	5.38e-06	0.000113	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.37e-06	0.000113	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	5.13e-06	0.000107	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—BCHE—epilepsy syndrome	5.1e-06	0.000107	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALB—epilepsy syndrome	5.08e-06	0.000106	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.92e-06	0.000103	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	4.91e-06	0.000103	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	4.87e-06	0.000102	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	4.82e-06	0.000101	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	4.8e-06	0.000101	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TH—epilepsy syndrome	4.8e-06	0.000101	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.72e-06	9.9e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	4.71e-06	9.88e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	4.69e-06	9.84e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	4.68e-06	9.8e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	4.67e-06	9.8e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	4.65e-06	9.75e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	4.65e-06	9.74e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.61e-06	9.67e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	4.48e-06	9.39e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—epilepsy syndrome	4.44e-06	9.32e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	4.44e-06	9.31e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	4.43e-06	9.28e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TH—epilepsy syndrome	4.41e-06	9.25e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	4.39e-06	9.2e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TH—epilepsy syndrome	4.38e-06	9.17e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.31e-06	9.03e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.21e-06	8.82e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	4.19e-06	8.79e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	4e-06	8.39e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	3.99e-06	8.37e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—BCHE—epilepsy syndrome	3.98e-06	8.34e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CAT—epilepsy syndrome	3.95e-06	8.28e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	3.84e-06	8.06e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	3.79e-06	7.95e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	3.75e-06	7.87e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TH—epilepsy syndrome	3.74e-06	7.84e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	3.68e-06	7.72e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.68e-06	7.72e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.65e-06	7.65e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CAT—epilepsy syndrome	3.63e-06	7.62e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.6e-06	7.55e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GPX1—epilepsy syndrome	3.57e-06	7.49e-05	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKT1—epilepsy syndrome	3.56e-06	7.46e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	3.54e-06	7.41e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	3.51e-06	7.35e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	3.29e-06	6.89e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.26e-06	6.83e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AGT—epilepsy syndrome	3.13e-06	6.57e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	3.12e-06	6.54e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CAT—epilepsy syndrome	3.08e-06	6.45e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOE—epilepsy syndrome	3.07e-06	6.44e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	3e-06	6.28e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.88e-06	6.04e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.86e-06	5.99e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.82e-06	5.92e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.8e-06	5.87e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GPX1—epilepsy syndrome	2.78e-06	5.84e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.64e-06	5.53e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AGT—epilepsy syndrome	2.44e-06	5.12e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.43e-06	5.08e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.41e-06	5.04e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.4e-06	5.04e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOE—epilepsy syndrome	2.39e-06	5.01e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKT1—epilepsy syndrome	2.23e-06	4.68e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALB—epilepsy syndrome	2.21e-06	4.64e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.19e-06	4.6e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	2.1e-06	4.41e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—POMC—epilepsy syndrome	2.06e-06	4.31e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.94e-06	4.06e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.92e-06	4.02e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.87e-06	3.93e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	1.64e-06	3.44e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.06e-06	2.22e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	9.73e-07	2.04e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	9.64e-07	2.02e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKT1—epilepsy syndrome	8.24e-07	1.73e-05	CbGpPWpGaD
